Raymond F. Vennare - 09 Sep 2025 Form 4 Insider Report for Predictive Oncology Inc. (POAI)

Role: Chief Executive Officer, Director
Signature: /s/ Josh Blacher, Attorney-in-Fact
Issuer symbol: POAI
Transactions as of: 09 Sep 2025
Net transactions value: $0
Form type: 4
Filing time: 11 Sep 2025, 17:40:09 UTC
Previous filing: 04 Jan 2023
Next filing: 02 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Vennare Raymond F	Chief Executive Officer, Director	C/O PREDICTIVE ONCOLOGY INC., 91 43RD STREET SUITE 110, PITTSBURGH	/s/ Josh Blacher, Attorney-in-Fact	11 Sep 2025	0001882090

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	POAI	Common Stock	Award	$0	+124,959	+1755%	$0.000000	132,081	09 Sep 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The grant consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs shall vest in full on October 31, 2025, subject to continued service through the applicable vesting date.